文献速递临床免疫质量管理与危急值

Architect i2000SR上批量提取法测定西罗莫司、他克莫司和环孢素的分析性能评价

Evaluation of a batched-extraction method for measurement of sirolimus, tacrolimus, and cyclosporine on the Architect i2000SR.
PubMed 文献 · Clin Chim Acta · 2022-04-04

本研究评估了Architect i2000SR上批量提取法测定西罗莫司、他克莫司和环孢素的分析性能,采用患者残余全血样本,评价不精密度、线性、方法比对及技师间差异。结果显示批量法不精密度和线性符合分析目标,与单个提取法相关性好,但所有药物ULOA和LLOA超出TAE或±15%,技师间差异范围相似,表明批量处理未增加或减少手工制备步骤的变异性。

要点

  • 批量提取法测定三种免疫抑制剂的不精密度和线性符合分析目标。
  • 批量法与单个提取法相关性好,但差异限超出TAE或±15%。
  • 批量处理未增加或减少因手工制备步骤导致的变异性。

核心结论

  • 批量提取法的不精密度和线性符合分析目标,与单个提取法相关性好。
  • 所有药物的ULOA和LLOA超出TAE或±15%,但技师间差异范围相似,批量处理未增加或减少手工制备的变异性。

研究设计与样本

  • 使用患者残余全血样本进行方法学评价,包括不精密度、线性、方法比对及技师间差异评估。

主要发现

  • 总不精密度:西罗莫司2.58-3.13%,他克莫司2.70-3.77%,环孢素7.82-12.41%。
  • 线性范围:西罗莫司0.44-19.49 μg/l,他克莫司0.05-26.15 μg/l,环孢素0.15-991.55 μg/l。
  • Deming回归分析显示技师间比对和批量与单个处理比对的斜率和截距均无显著性。
  • Bland-Altman分析:西罗莫司平均偏差1.29%(LLOA:-14.63%,ULOA:17.21%),他克莫司2.07%(LLOA:-10.87%,ULOA:15%),环孢素-1.56%(LLOA:-20.05%,ULOA:16.94%)。
  • 上述数值与技师间比对观察到的偏差和LLOA无显著差异。

关键数值与推荐

  • 总不精密度:西罗莫司2.58-3.13%,他克莫司2.70-3.77%,环孢素7.82-12.41%。
  • 线性范围:西罗莫司0.44-19.49 μg/l,他克莫司0.05-26.15 μg/l,环孢素0.15-991.55 μg/l。
  • Bland-Altman分析:西罗莫司平均偏差1.29%(LLOA:-14.63%,ULOA:17.21%),他克莫司2.07%(LLOA:-10.87%,ULOA:15%),环孢素-1.56%(LLOA:-20.05%,ULOA:16.94%)。
  • 所有药物ULOA和LLOA超出TAE或±15%。

临床怎么用

  • 批量提取法可用于Architect i2000SR上西罗莫司、他克莫司和环孢素的测定,分析性能符合要求。
  • 但批量法与单个提取法差异限超出TAE或±15%,需结合技师间差异范围解读结果。

局限性

  • 未报告样本量、具体TAE值及临床影响评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Manual extraction of immunosuppressants is required before measurement on the Architect immunoassay analyzer. The individual extraction of samples places clinical laboratory staff at risk for ergonomic injury. We evaluated the analytical performance of a batched extraction method for measuring sirolimus, tacrolimus, and cyclosporine using the Architect i2000SR. METHODS: Residual whole blood samples from patients receiving immunosuppressant therapy were used for evaluation. The analytical evaluation included imprecision, linearity, and method comparison. Technologist-to-technologist variation was also assessed. RESULTS: Total imprecision ranged from 2.58 to 3.13% for sirolimus, 2.70-3.77% for tacrolimus, and 7.82-12.41% for cyclosporine. Linearity was verified from 0.44-19.49 μg/l for sirolimus, 0.05-26.15 μg/l for tacrolimus, and 0.15-991.55 μg/l for cyclosporine. Deming regression analysis showed slope and intercept were not significant for either technologist-to-technologist comparison or for batched vs. individual processing comparison. Bland-Altman analysis of individual vs. batched processing revealed a mean bias of 1.29% (LLOA: -14.63%, ULOA: 17.21%) for sirolimus, 2.07% (LLOA: -10.87%, ULOA: 15%) for tacrolimus, and -1.56% (LLOA: -20.05%, ULOA: 16.94%) for cyclosporine. The values were not significantly different from the bias and LLOAs observed for technologist-to-technologist comparison. CONCLUSIONS: The imprecision and linearity of batched methods met analytical goals. The batched method also correlated well with the individual extraction methods. The ULOA and LLOA for all drugs tested exceeded a TAE or ± 15%. However, similar range of differences was observed between technologists, suggesting that batch processing did not increase or reduce variability due to manual preparation steps.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Di Meo A, Youkhana S, Khalifeh S, et al. Evaluation of a batched-extraction method for measurement of sirolimus, tacrolimus, and cyclosporine on the Architect i2000SR. Clin Chim Acta. 2022. PMID: 35390337. doi:10.1016/j.cca.2022.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。